Additionally, we validated both PLK1 mRNA and protein levels across benign, prostrate carcinoma and metastatic prostate cancer tissues by qPCR and immunoblot analysis, respectively (Supplementary Figures S7c and d), which confirmed the direct correlation between SUB1 and PLK1. This evidence concerns the gene PLK1 and prostate carcinoma.